Hyperuricemia: Serum Urate and the Crystal-Formation Threshold

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

Blood testing for hyperuricemia measures serum uric acid—the end product of purine catabolism—to determine whether levels exceed the crystal-formation threshold of ~6.8 mg/dL. Adult reference ranges are roughly 3–7 mg/dL in men and 2–6 mg/dL in women, with treat-to-target goals for gout <6 mg/dL. Trending uric acid is associated with identifying crystal-related disease risk and may help support monitoring of urate-lowering therapy.

Read more →

Understand what your kidney function testing results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

Hyperuricemia and the markers that reveal it

Hyperuricemia biomarkers tell you how much uric acid your body is carrying and how well you are clearing it. The central marker is serum urate—the circulating form of uric acid made when the body breaks down purines from your own cells and food (purine catabolism via xanthine oxidoreductase in liver and intestine). This level reflects a balance between production and disposal: the kidneys and, to a lesser extent, the gut move urate out of the body using specific transporters (URAT1/SLC22A12, GLUT9/SLC2A9, ABCG2). Complementary measures, such as uric acid in urine and its fractional excretion, indicate how the kidneys are handling that load. Together, these biomarkers signal the biological pressure for monosodium urate crystals to form in joints, tendons, and kidneys—the step that can trigger gouty inflammation and stone formation. Because hyperuricemia is often silent until crystals appear, testing brings the process into view early, helps clarify whether excess comes from overproduction or under-excretion, and anchors simple, targeted strategies to lower the body’s urate burden.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Reading a urate result

Serum uric acid is the key biomarker for hyperuricemia—the end product of purine metabolism that the kidneys and gut must clear. When it accumulates, it can crystallize in joints and kidneys, triggering inflammation and pain. It also signals broader metabolic and vascular stress that affects heart, liver, and brain over time. Typical adult values are about 3–7 in men and 2–6 in women (lower before menopause). Crystal formation risk rises above roughly 6.8. For most people, risk appears lowest in the mid‑to‑lower part of the reference range. Very low values usually reflect reduced production (rare enzyme defects, severe liver disease, undernutrition) or increased kidney loss (tubular disorders or certain medications). Most people feel fine, but some develop uric acid kidney stones or exercise‑related flank pain and acute kidney injury in hereditary renal hypouricemia. Low uric acid can also accompany dilutional states such as SIADH.Higher values point to a mismatch between production and excretion. They raise the likelihood of gout flares (sudden, severe joint pain, often in the big toe), tophi, and uric acid stones, and are linked to chronic kidney disease, hypertension, insulin resistance, and fatty liver. Men tend to run higher earlier in life; women rise after menopause. In pregnancy, elevated levels correlate with preeclampsia and fetal growth problems; in teens, rising levels with obesity can mark metabolic risk. Big picture, uric acid connects purine turnover to kidney handling, vascular tone, and inflammatory pathways. Testing helps map that balance, identify crystal‑related disease risk, and anticipate long‑term outcomes across joints, kidneys, and cardiometabolic health.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

What a uric-acid reading reveals — and what it doesn't

Hyperuricemia blood testing provides insight into how your body manages purine metabolism, which is closely tied to energy production, cardiovascular health, kidney function, and inflammation. At Superpower, we assess this system by measuring uric acid, the key biomarker for hyperuricemia. Understanding your uric acid level helps reveal how well your body is balancing the breakdown and elimination of purines, which are natural compounds found in your cells and in many foods. Uric acid is a waste product formed when your body metabolizes purines. Normally, uric acid dissolves in the blood, passes through the kidneys, and is excreted in urine. Hyperuricemia occurs when uric acid builds up in the blood, either because the body produces too much or the kidneys do not remove enough. Elevated uric acid is the defining feature of hyperuricemia and is central to its diagnosis. Stable uric acid levels support healthy joint, kidney, and vascular function. When uric acid remains within a healthy range, it helps maintain the stability of connective tissues and blood vessels, and reduces the risk of crystal formation that can trigger inflammation. Persistent elevations can disrupt these systems, increasing the risk for gout, kidney stones, and possibly contributing to cardiovascular and metabolic disturbances. Interpretation of uric acid results depends on several factors. Levels can vary with age, sex, genetics, kidney function, and certain medications. Pregnancy, acute illness, and recent dietary changes can also influence results. Laboratory methods may differ, so reference ranges can vary between testing sites.

Frequently Asked Questions

References

  1. FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, Gelber AC, Harrold LR, Khanna D, King C, Levy G, Libbey C, Mount D, Pillinger MH, Rosenthal A, Singh JA, Sims JE, Smith BJ, Wenger NS, ... Neogi T (2020). 2020 American College of Rheumatology guideline for the management of gout. *Arthritis Care & Research*, *72*(6), 744-760. https://doi.org/10.1002/acr.24180
  2. Dalbeth N, Gosling AL, Gaffo A, Abhishek A (2021). Gout. *Lancet*, *397*(10287), 1843-1855. https://doi.org/10.1016/S0140-6736(21)00569-9
  3. Borghi C, Rosei EA, Bardin T, Dawson J, Dominiczak A, Kielstein JT, Manolis AJ, Perez-Ruiz F, Mancia G (2015). Serum uric acid and the risk of cardiovascular and renal disease. *Journal of Hypertension*, *33*(9), 1729-1741. https://doi.org/10.1097/HJH.0000000000000701
  4. Bobulescu IA, Moe OW (2012). Renal transport of uric acid: Evolving concepts and uncertainties. *Advances in Chronic Kidney Disease*, *19*(6), 358-371. https://doi.org/10.1053/j.ackd.2012.07.009
  5. National Institute of Arthritis and Musculoskeletal and Skin Diseases. (2024). *Gout*. https://www.niams.nih.gov/health-topics/gout

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey